In last trading session, MoonLake Immunotherapeutics (NASDAQ:MLTX) saw 0.33 million shares changing hands with its beta currently measuring 1.27. Company’s recent per share price level
During the last session, MoonLake Immunotherapeutics (NASDAQ:MLTX)’s traded shares were 0.43 million, with the beta value of the company hitting 1.25. At the end of
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
